☆ 4.6 Article

Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study

TRANSPLANTATION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine Secondary Analysis of a Randomized Trial

Deepali Kumar et al.

Summary: This study assessed neutralizing antibody responses against SARS-CoV-2 variants in transplant recipients after receiving a third dose of mRNA vaccine. The results showed that the third dose of vaccine could enhance the neutralizing antibody response against variant viruses.

ANNALS OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

Olivia S. Kates et al.

Summary: The mortality rate among SOT recipients hospitalized for COVID-19 was 20.5%, with age and underlying comorbidities being the major drivers of mortality, rather than measures related to immunosuppression intensity.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Infectious Diseases

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

Bradley J. Langford et al.

Summary: The study estimated that approximately three-quarters of patients with COVID-19 receive antibiotic treatment, which is significantly higher than the estimated prevalence of bacterial co-infection. This suggests a potential for high rates of unnecessary antibiotic use in patients with COVID-19.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

I. O. Rosas et al.

Summary: In this randomized trial involving hospitalized patients with severe Covid-19 pneumonia, the use of tocilizumab did not result in significantly better clinical status or lower mortality than placebo at 28 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Urology & Nephrology

Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Demetra Tsapepas et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Surgery

Response to SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients

Maricar Malinis et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Letter Surgery

Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients

Maricar Malinis et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Surgery

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients

Victoria G. Hall et al.

Summary: Solid organ transplant recipients are at high risk of severe COVID-19. A study on the immunogenicity of mRNA-1273 vaccine in this population showed that a subset of patients developed neutralizing antibodies and CD4+ T cell responses, emphasizing the importance of vaccination in this patient population.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

Jan Havlin et al.

Summary: Transplant recipients showed weaker antibody response to mRNA COVID-19 vaccine compared to natural infection, with only a subset of patients demonstrating SARS-CoV-2 specific T-cell response. Further research is needed to identify the optimal vaccine type and schedule for immunocompromised transplant patients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

添加到收藏夹

Letter Urology & Nephrology

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard et al.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

Venkata-Viswanadh Edara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients

Saima Aslam et al.

Summary: The study found that COVID-19 vaccination significantly reduced the incidence of symptomatic COVID-19 in solid organ transplant recipients, demonstrating real-world clinical effectiveness.

TRANSPLANT INFECTIOUS DISEASE (2021)

添加到收藏夹

Letter Immunology

Early experience with SARs-CoV-2 mRNA vaccine breakthrough among kidney transplant recipients

Chelsey Chenxi Song et al.

TRANSPLANT INFECTIOUS DISEASE (2021)

添加到收藏夹

Editorial Material Immunology

Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients

Concetta Catalano et al.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Nicole M. Ali et al.

TRANSPLANTATION (2021)

添加到收藏夹

Article Immunology

Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients

Tina Marinelli et al.

Summary: This study illustrates the range of COVID-19 illness in transplant patients, identifying risk factors for severe disease. The majority of patients developed antibodies by two weeks, with varying stability over time. Prolonged viral shedding was observed in a minority of patients.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients

Caroline X. Qin et al.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida

Shweta Anjan et al.

TRANSPLANTATION (2021)

添加到收藏夹

Letter Immunology

Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis

Rommel Ravanan et al.

TRANSPLANTATION (2021)

添加到收藏夹

Article Health Care Sciences & Services

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Julian Stumpf et al.

Summary: The study showed that dialysis patients had a high seroconversion rate after receiving the boost vaccination, while the majority of transplant recipients had impaired humoral responses. The type and number of immunosuppressive drugs, as well as the type of vaccine, were major determinants of seroconversion failure in both dialysis and transplant patients.

LANCET REGIONAL HEALTH-EUROPE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

Timothy A. Bates et al.

Summary: The study shows that serum from BNT162b2 vaccine recipients and convalescent COVID-19 patients has lower neutralization efficiency against SARS-CoV-2 variants B.1.1.7 and B.1.351, and this is negatively associated with patient age. The emerging SARS-CoV-2 variants are found to escape neutralization by serum antibodies, potentially leading to increased risk of reinfection or vaccine breakthrough.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Surgery

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Marcus R. Pereira et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Fitting Linear Mixed-Effects Models Using lme4

Douglas Bates et al.

JOURNAL OF STATISTICAL SOFTWARE (2015)

添加到收藏夹

Article Statistics & Probability

MatchIt: Nonparametric Preprocessing for Parametric Causal Inference

Daniel E. Ho et al.

Journal of Statistical Software (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.